These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Gene mutation analysis and immunohistochemical study of beta-catenin in odontogenic tumors. Miyake T; Tanaka Y; Kato K; Tanaka M; Sato Y; Ijiri R; Inayama Y; Ito Y; Aoki S; Kawabe R; Tohnai I Pathol Int; 2006 Dec; 56(12):732-7. PubMed ID: 17096730 [TBL] [Abstract][Full Text] [Related]
5. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations. Sekine S; Shibata T; Kokubu A; Morishita Y; Noguchi M; Nakanishi Y; Sakamoto M; Hirohashi S Am J Pathol; 2002 Dec; 161(6):1997-2001. PubMed ID: 12466115 [TBL] [Abstract][Full Text] [Related]
6. Beta-catenin gene alterations in a variety of so-called calcifying odontogenic cysts. Ahn SG; Kim SA; Kim SG; Lee SH; Kim J; Yoon JH APMIS; 2008 Mar; 116(3):206-11. PubMed ID: 18377586 [TBL] [Abstract][Full Text] [Related]
7. Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation. Sekine S; Takata T; Shibata T; Mori M; Morishita Y; Noguchi M; Uchida T; Kanai Y; Hirohashi S Histopathology; 2004 Dec; 45(6):573-9. PubMed ID: 15569047 [TBL] [Abstract][Full Text] [Related]
8. Aberrant beta-catenin expression and adenomatous polyposis coli gene mutation in ameloblastoma and odontogenic carcinoma. Siriwardena BS; Kudo Y; Ogawa I; Tilakaratne WM; Takata T Oral Oncol; 2009 Feb; 45(2):103-8. PubMed ID: 18486530 [TBL] [Abstract][Full Text] [Related]
9. Odontogenic classification of craniopharyngiomas: a clinicopathological study of 54 cases. Paulus W; Stöckel C; Krauss J; Sörensen N; Roggendorf W Histopathology; 1997 Feb; 30(2):172-6. PubMed ID: 9067743 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of beta-catenin and adenomatous polyposis coli in ameloblastomas. Kumamoto H; Ooya K J Oral Pathol Med; 2005 Aug; 34(7):401-6. PubMed ID: 16011608 [TBL] [Abstract][Full Text] [Related]
11. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941 [TBL] [Abstract][Full Text] [Related]
12. The relationship of adamantinomatous craniopharyngioma to ghost cell ameloblastoma of the jaws: a histopathologic and immunohistochemical study. Badger KV; Gardner DG J Oral Pathol Med; 1997 Sep; 26(8):349-55. PubMed ID: 9379423 [TBL] [Abstract][Full Text] [Related]
13. Localization of beta catenin across the domain of odontogenic lesions: A systematic review. Chatterjee S; Devi A; Kamboj M; Narwal A J Oral Pathol Med; 2023 Nov; 52(10):904-910. PubMed ID: 37840228 [TBL] [Abstract][Full Text] [Related]
14. BRAFV600E mutation in the diagnosis of unicystic ameloblastoma. Pereira NB; Pereira KM; Coura BP; Diniz MG; de Castro WH; Gomes CC; Gomez RS J Oral Pathol Med; 2016 Nov; 45(10):780-785. PubMed ID: 27084044 [TBL] [Abstract][Full Text] [Related]
15. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas. Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490 [TBL] [Abstract][Full Text] [Related]
17. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Buslei R; Nolde M; Hofmann B; Meissner S; Eyupoglu IY; Siebzehnrübl F; Hahnen E; Kreutzer J; Fahlbusch R Acta Neuropathol; 2005 Jun; 109(6):589-97. PubMed ID: 15891929 [TBL] [Abstract][Full Text] [Related]
18. DNA ploidy of ameloblastoma and ameloblastic carcinoma of the jaws. Analysis by image and flow cytometry. Müller S; DeRose PB; Cohen C Arch Pathol Lab Med; 1993 Nov; 117(11):1126-31. PubMed ID: 8239934 [TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of Wnt signaling molecules in ameloblastoma with aberrant nuclear expression of beta-catenin. Tanahashi J; Daa T; Yada N; Kashima K; Kondoh Y; Yokoyama S J Oral Pathol Med; 2008 Oct; 37(9):565-70. PubMed ID: 18284543 [TBL] [Abstract][Full Text] [Related]
20. beta-Catenin is expressed aberrantly in tumors expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst. Hassanein AM; Glanz SM; Kessler HP; Eskin TA; Liu C Am J Clin Pathol; 2003 Nov; 120(5):732-6. PubMed ID: 14608900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]